Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network · 2025-02 · 23 (2) · 41-62
DOI: 10.6004/jnccn.2025.0006 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025-02. Verfasst von Hiroto Inaba und 32 weiteren Autor:innen. Beteiligte Einrichtung: St. Jude Children's Research Hospital/The University of Tennessee Health Science Center. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Medical Oncology. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 162 Literaturangaben.
Abstract (Originalsprache)
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Acute Lymphoblastic Leukemia (ALL) were developed as a result of meetings convened by a multidisciplinary panel of pediatric ALL experts, with the goal of providing recommendations on standard treatment approaches based on current evidence. The NCCN Guidelines for pediatric ALL focus on risk assessment and stratification of risk-adapted therapy; treatment strategies for BCR::ABL1 (Philadelphia chromosome [Ph])-negative and BCR::ABL1 -positive B-cell lineage, T-cell lineage, and infant ALL; and supportive care considerations. This selection from the NCCN Guidelines for pediatric ALL focuses on the diagnosis of and management of pediatric T-ALL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
- Abramson Cancer Center at the University of Pennsylvania/Children's Hospital of Philadelphia.
- Fred Hutchinson Cancer Center/Seattle Children's Hospital.
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center/Riley Children's Health.
- Fred & Pamela Buffett Cancer Center/Children's Hospital & Medical Center.
- The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute/Nationwide Children's Hospital.
Zitieren
APA
Inaba, H., Teachey, D., Annesley, C., Batra, S., Beck, J., Colace, S., Cooper, S., Dallas, M., Oliveira, S., Kelly, K., Kitko, C., Kohorst, M., Kutny, M., Lacayo, N., Lee-Miller, C., Ludwig, K., Madden, L., Maloney, K., Mangum, D., …, & Stehman, K. (2025). Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network, 23(2), 41-62. https://doi.org/10.6004/jnccn.2025.0006
Vancouver
Inaba H, Teachey D, Annesley C, Batra S, Beck J, Colace S, et al. Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network. 2025;23(2):41-62. doi:10.6004/jnccn.2025.0006
BibTeX
@article{Inaba2025,
author = {Inaba, Hiroto and Teachey, David and Annesley, Colleen and Batra, Sandeep and Beck, Jill and Colace, Susan and Cooper, Stacy and Dallas, Mari and Oliveira, Satiro De and Kelly, Kara and Kitko, Carrie and Kohorst, Mira and Kutny, Matthew and Lacayo, Norman and Lee-Miller, Cathy and Ludwig, Kathleen and Madden, Lisa and Maloney, Kelly and Mangum, David and Massaro, Stephanie and McCall, David and Morocco, Perry and Muller, Brad and Murphy, Lindsey and Nardi, Valentina and Rossoff, Jenna and Schuettpelz, Laura and Shah, Bijal and Sun, Jessica and Wong, Victor and Yanik, Gregory and Awotiwon, Ajibola and Stehman, Katie},
title = {Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2025},
volume = {23},
number = {2},
pages = {41--62},
doi = {10.6004/jnccn.2025.0006}
}
EUVIMED